CAT and neoplasm: In “cold” tumor models, for example, a multifunctional nanotherapeutic system including GF-Ala, catalase, and the TLR7/8 agonist R848 in a PEG-PLGA matrix demonstrated significant TME remodeling, tumor regression, and inhibition of metastases [136].